This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: We used clinical and genetic data from the UK to analyse the disparity between the incidence of malignant hyperthermia (MH) reactions and the prevalence of variants in the RYR1 gene associated with susceptibility to MH. We examined whether these data are consistent with the clinical risk of MH being inherited as an autosomal dominant trait. METHODS: The numbers of general anaesthetics delivered in the UK and population data were estimated from national sources. The prevalence of RYR1 variants in the UK population was estimated using UK Biobank data. Bayesian probabilistic modelling calibrated against actual data was used to estimate the prevalence of the clinical risk of MH in the UK (anchored to the incidence of MH reactions from 1988 to 1993) to evaluate the mode of inheritance of the clinical risk of MH and the relative risk associated with different RYR1 variants. The risk of MH varied by up to 125-fold among those with 28 recurrent RYR1 variants. CONCLUSIONS: These findings support a threshold inheritance model for clinical MH, with implications for diagnostics, both genotyping and in vitro contracture test phenotyping.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Aboelsaod et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: